Background: Several reports indicated that volunteers enrolled in preventive trials tend to show a different profile, with respect to sociodemographic characteristics, health-related behaviors, or medical history, compared with the source population. We conducted an incidence and mortality follow-up within a cohort of subjects who had been mailed a recruitment questionnaire in the SCORE trial of sigmoidoscopy (FS) screening for colorectal cancer (CRC) to assess the impact of self-selection in the study of volunteers willing to be screened on the outcomes estimates and on the generalizability of the results.
article
The large randomized trials that recently documented a favorable effect of flexible sigmoidoscopy (FS) screening on colorectal cancer (CRC) incidence and mortality were conducted among volunteers recruited by media campaigns (11) or selfselected from population samples (12, 13) . The two-stage recruitment adopted in the European trials resulted in a substantial increase in the attendance rate, compared with the uptake in pilot population projects (14) (15) (16) , thus increasing the study efficiency. However, in the Italian trial (SCORE), such strategy resulted in the enrolment of a small (16%) proportion of the target population (17) . Although this selection process does not affect the internal validity of the trial, as only eligible responders were randomly assigned, it might influence the generalizability of the findings.
The impact of self-selection was previously investigated by comparing sociodemographic characteristics and mortality rates observed among people enrolled in preventive trials with those expected based on census and vital statistics (2) (3) (4) 6, 7) or on national health surveys data (1) . However, this approach did not allow performance of multivariable analyses using individual data.
In the SCORE trial, all subjects targeted for recruitment were identified and they were required to declare their interest in having screening (17) . This analysis aimed to assess the impact of characteristics associated with self-selection of volunteers willing to be screened on the estimates of the trial outcomes and on the generalizability of the findings.
Methods

Study Population
The SCORE trial (ISRCTN27814061) was conducted in six Italian centers following approval by the local ethics committees. The design has been described elsewhere (17) . Briefly, in all centers a random sample of residents age 55 to 64 years were mailed an interest-in-screening questionnaire designed to assess eligibility for and interest in flexible sigmoidoscopy (FS) screening, with an accompanying letter giving brief information about the test and explaining the rationale of the study. A prepaid envelope for returning the questionnaire was provided. No reminder was sent to nonresponders. Responders were not eligible if they reported: 1) personal history of CRC, colorectal adenomas, or inflammatory bowel disease, 2) colorectal endoscopy within the previous two years, 3) more than one first-degree relative (FDR) with CRC, or 4) a medical condition precluding a benefit from screening. Eligible respondents indicating that they would certainly, or probably, undergo FS if offered it, were randomly assigned (ratio 1:1) to intervention (FS screening) or control arm (no further contact). All participants gave written informed consent to the study procedures.
We included in the present analysis all subjects targeted for recruitment in Turin and Genoa, where individual information concerning sociodemographic characteristics were available from the local population registers both for responders and for nonresponders. An organized population-based screening program was started in 2012 in Genoa and in 2004 in Turin. In both centers, in 2007, about 9% of people age 50 to 69 years reported having performed a fecal occult blood test within the previous 2 years or a TC (colonoscopy) within the previous five yeas (18) .
In Turin all individuals in the target age range, listed in the rosters of a random sample of general practitioners (GPs), were mailed the questionnaire. GPs were stratified according to the proportion of eligible respondents and then randomly assigned (ratio 1:1) within each class of response rate, based on a computer-generated random numbers sequence. In Genoa, a random sample of individuals in the target age range was drawn from the National Health Service (NHS) register. Eligible subjects were randomly assigned (ratio 1:1) on an individual basis, using a computer-generated allocation schedule.
Subjects assigned to the intervention arm were excluded from the present comparative analysis, because their CRC risk was reduced as a result of screening. Subjects assigned to the control arm represented a selected subgroup of healthier volunteers compared with nonresponders: indeed, in addition to the self-selection of subjects responding to screening questionnaire, control patients were further selected to meet the stipulated eligibility criteria for enrolment, while the necessary information to asses eligibility was not available for those subjects who did not respond.
Therefore, to ensure the validity of the comparison (ie, eliminating the additional selection introduced by enrolment procedure), we considered in the analysis three response groups: 1) nonresponders, 2) uninterested responders, including both eligible and ineligible subjects who stated they would have probably or definitely refused FS screening if offered it, and 3) interested responders, including those responders who stated they would have certainly or probably undergone FS if offered. As these subjects were randomly assigned only if they met the eligibility criteria; we included in this group both subjects assigned to the control group and a sample of ineligible responders willing to volunteer for screening. In Turin, interested responders included all subjects willing to volunteer for screening listed in the rosters of the GPs assigned to the control arm. In Genoa, this group included a random sample (ratio 1:1) of ineligible responders willing to volunteer for screening together with subjects assigned to the control group.
Incidence and Mortality Follow-up
The incidence follow-up was based on an automated recordlinkage of the study archives with the population cancer registries covering the geographic areas of the two centers. The vital status was ascertained through an automated record linkage, using two independent identifiers (social security number and an algorithm derived from name, surname, and birth date), with the regional mortality registries, which also record the causes of death. The inception of follow-up was set at the time of random assignment. For subjects who were not randomly assigned, the reference date was set at 30 days after the mailing date of the recruitment questionnaire. Subjects who moved outside the geographic area (region) covered by the archives used for the mortality and incidence follow-up were classified as "emigrated." The follow-up time of people who emigrated, were diagnosed with CRC (CRC incidence models only), or died was censored at the date of the event; it ended on December 31, 2008 for all other subjects.
Classification of CRC Cases
Only invasive adenocarcinomas (ICD-O2 codes) of the colon and rectum were classified as CRC cases for the purposes of the analysis. In situ or intramucosal carcinomas, squamous or basal cell carcinomas of the anal skin, neuroendocrine tumors, sarcomas, lymphomas, colorectal localizations of other primary malignancies and all lesions located at the anal sites (ICD-9-CM [19] code: 154.2, 154.3) were censored at the time of death, emigration, or end of follow-up, and if deceased they were counted as events only when estimating overall mortality risk. CRC arising in the descending colon, sigmoid, recto-sigmoid junction, and rectum (ICD-9-CM [19] codes: 153.2, 153.3, 154.0, 154.1) were classified as distal; proximal CRCs included those located proximally to the descending colon (codes 153.0, 153.1, and 153.4-153.8), whereas unspecified sites were those coded as 153.9. Multiple synchronous CRCs were classified once, based on the code of the more distal lesion.
Education was categorized as: low (0-5 years), referent group, intermediate (6-8 years) , high (≥9 years). Based on the geographic gradient of CRC incidence in Italy (20) , the area of birth was grouped in four categories (Turin and Genoa areas, other Northern-Central Italy areas, Southern Italy, foreign countries). Marital status was categorized as married (including partners living together) and single (including unmarried, widowed).
The primary outcomes of the analysis were CRC incidence and mortality. Secondary outcomes were CRC site-specific mortality and all-cause mortality. The underlying cause of death indicated in the death certificates was used for the cause-specific observed counts.
Statistical Analysis
We computed the average rates per 1000 person-years (PYs), deriving their 95% confidence intervals by using the standard error of the log transformation of the rates (21) .
A multinomial regression model was fitted to study the association of subject's sociodemographic characteristics with the type of response to the recruitment questionnaire. A multivariable logistic regression model was fitted to study determinants of interest in screening among responders. A Cox regression model was used to compare CRC risk and CRC specific and allcause mortality across the response groups, adjusting for subject's characteristics. Proportional hazards (PH) assumption was assessed using the method proposed by Lin et al. (22) and by checking the cumulative incidence curves. All statistical tests were two-sided, assuming the standard .05 level of statistical significance. The SAS software (SAS 9.2, SAS Institute Inc., Cary, NC) was used for all the analyses.
Results
We mailed the interest in screening questionnaire to 153 909 people, and 37 121 (24.1%) replied: 19.3% in Genoa (17 496/90 786) and 31.1% in Turin (19 622/63 120). After excluding people assigned to the intervention (n = 10 119) and including the random sample (n = 3612) of ineligible interested responders attributed to the control group (Figure 1) , according to the procedures described above, 140 104 subjects were considered for this analysis. Following the linkage of the study database with the regional archives, we found that 676 (0.5%) subjects had been diagnosed with CRC, 239 (0.2%) had died, and 355 (0.3%) had moved outside the study area before random assignment, while 169 (0.1%) were no longer traceable (Figure 1) . A detailed description of the reasons for exclusion by response group and trial center is reported in Supplementary Tables 1-3 (available online) .
The distribution across the response groups of the 138 665 subjects included in the analysis is reported in Table 1 . The observed association of marital status, educational level, and birthplace with the likelihood to respond to the interest in screening questionnaire was confirmed also in the multinomial logistic regression analysis both for interested and uninterested responders (data not shown): Both interested (odds ratio [OR] intermediate education = 2.04, 95% confidence interval
[CI] = 1.95 to 2.14; OR high education = 2.66, 95% CI = 2.54 to 2.79) and uninterested responders (OR intermediate education = 1.51, 95% CI = 1.44 to 1.60; OR high education = 1.81, 95% CI = 1.71 to 1.91) were better educated compared with nonresponders. They were also more likely to be married (OR interested = 1.28, 95% CI = 1.22 to 1.34; OR uninterested = 1.16, 95% CI = 1.10 to 1.23) and less likely to be born in Southern Italy (OR interested = 0.61, 95% CI = 0.58 to 0.64; OR uninterested = 0.60, 95% CI = 0.56 to 0.64).
Restricting the analysis to responders (Table 2) , those expressing their interest in having screening were more likely to be male (OR = 1.55, 95% CI = 1.46 to 1.64), younger than age 60 years (OR = 1.28, 95% CI = 1.22 to 1.35), married (OR = 1.10, 95% CI = 1.03 to 1.17), better educated (intermediate education: OR =1.35, 95% CI = 1.27 to 1.45; high education: OR = 1.47, 95% CI = 1.37 to 1.58), to report one or more FDR with CRC (OR = 2.14, 95% CI = 1.93 to 2.38), or to mention a condition listed among exclusion criteria (OR = 1.36, 95% CI = 1.23 to 1.50).
CRC Incidence
The median follow-up time was 11.2 years (10-90 percentile range = 6.3 to 12.6) providing 1 466 838.6 PYs of observation: 2677 subjects were diagnosed with an invasive CRC, resulting in an incidence rate of 1.83 per 1000 PYs (95% CI = 1.76 to 1.90). In both univariate and multivariable analyses (Table 3) , CRC incidence was statistically significantly higher among men and among people aged 60 to 64 years, compared with women and subjects younger than 60 years, while no association was observed with educational level, marital status, birthplace, trial center, or response group.
CRC and All-Cause Mortality
The median follow-up time was 11.2 years (10-90 percentile range = 6.7 to 12.6), providing 1 470 840.0 PYs of observation: 16 794 subjects died during the follow-up period (11.42 per 1000 PYs; 95% CI = 11.25 to 11.59) and in 881 cases the death was attributed to CRC, resulting in a CRC mortality rate of 0.60 per 1000 PYs (95% CI = 0.56 to 0.64). Among the 2677 patients with incident CRC, the proportion of deaths attributed to CRC was 77.3% among uninterested responders, 83.8% among nonresponders, and 87.7% among interested responders. CRC and allcause mortality (Table 4) were statistically significantly higher among men and among older people compared with women and subjects younger than 60 years, and they were statistically significantly lower among interested responders than among nonresponders. All-cause mortality was also statistically significantly higher among subjects living alone, and it showed a strong inverse association with educational level (Table 4) . These associations were maintained after adjusting for individuals' characteristics and response status, both for CRC and all-cause mortality (Table 5) .
CRC mortality was 30% lower among interested responders (HR = 0.70, 95% CI = 0.54 to 0.91) compared with nonresponders; the same reduction (HR = 0.72, 95% CI = 0.53 to 0.97) was observed when comparing eligible interested responders randomly assigned to the control group with nonresponders (data not shown). The lower risk of CRC death among interested responders was mainly attributable to a reduction of distal CRC mortality (HR = 0.65, 95% CI = 0.45 to 0.93); the reduction in the risk of proximal CRC death (HR = 0.77, 95% CI = 0.52 to 1.16) did not reach the level of statistical significance (data not shown).
article All-cause mortality was reduced both among interested (HR = 0.61, 95% CI = 0.57 to 0.65) and uninterested responders (HR = 0.81, 95% CI = 0.76 to 0.86), and it showed a strong inverse association (Table 5 ) with the subject's educational level (intermediate vs low: HR = 0.86, 95% CI = 0.83 to 0.89; high vs low: HR = 0.70, 95% CI = 0.67 to 0.73).
Discussion
In a large sample of average-risk people targeted for recruitment in a preventive intervention trial, sociodemographic characteristics were associated with individuals' willingness to participate. Both subjects who had declared their interest in undergoing screening in the SCORE trial and those who were not interested were better educated than nonresponders to the interest-in-screening questionnaire. Among responders, men, people younger than 60 years, better educated, or with a positive FH for CRC were more likely to volunteer.
Over 11 years follow-up, interested responders showed a similar CRC risk as nonresponders, but their risk of CRC death and all-cause mortality were substantially lower (by 30% and 39%, respectively). Responders not interested in having screening showed a similar CRC risk as nonresponders and a statistically significant decrease in all-cause (19%) but not in CRC article mortality. Of note, these findings are not resulting from the selective exclusion of prevalent disease among enrolled subjects, as all CRC case patients diagnosed before the inception of follow-up were excluded both among responders and nonresponders, following the same procedure, and all responders free of CRC at the time of random assignment (including those mentioning some exclusion criteria) were retained in the mortality analysis.
The finding of a similar CRC incidence among nonresponders as among responders (and among subjects randomly assigned to the control group) would indicate that a similar protective effect of screening on CRC risk can be expected when extending the intervention to the general target population.
The lower CRC mortality documented among interested responders compared with nonresponders reduced the power of the SCORE trial to detect a statistically significant protective effect of screening on CRC mortality, on an intentionto-treat basis. This would also suggest that the impact of FS screening on CRC mortality might be larger when extending the intervention to the general population. Given the higher CRC mortality among nonresponders to the recruitment questionnaire (about 75% of the target population), the NNS to prevent one CRC death would decrease by about 30%, compared with the estimate based on the trial results, assuming the same relative reduction of the risk of CRC death. Also, as long as the higher mortality rate among nonresponders may be related to a delayed diagnosis and access to effective treatment, screening might have a larger impact on mortality in this subgroup than among volunteers enrolled in the trial. A low participation rate might, however, limit screening impact in this hard-to-reach group.
Overall mortality was higher among nonresponders (including those diagnosed with CRC) than among interested responders. However, the proportion of deaths attributed to CRC among CRC patients was the same in both groups, which would suggest that the burden of CRC mortality was also similar.
The self-selection of better-educated people observed in our screening trial has been documented also in previous preventive studies (1,2,6,7) . Similarly, the lack of association of CRC risk with educational status, which can be considered article (23) a valid indicator of socioeconomic status (SES), is consistent with previous reports (23) (24) (25) (26) (27) , suggesting that CRC incidence may not be associated with SES. Those same studies showed that the risk of death among CRC patients tends to be higher among the less affluent. In our cohort, after adjusting for response status, education was not associated with CRC mortality, which was instead 30% lower among interested responders than among nonresponders. The association of responders' availability for enrollment with the risk of CRC-related death, would suggest that interest in screening may be considered an indicator of a higher level of CRC risk awareness. Although we do not have information concerning the stage at diagnosis of CRCs diagnosed among nonresponders, it seems likely that increased individual's awareness could favor utilization of preventive tests (28) or timely contact with a physician at the onset of alarming symptoms (29) found to be associated with the higher likelihood of being diagnosed with a less advanced disease for subjects with high SES. Indeed, although the 11-year risk was the same across response groups, the cumulative incidence curves were suggestive of a higher incidence in the initial six years of follow-up among interested responders, likely reflecting a trend toward an anticipation of CRC diagnosis in this group, compared with nonresponders. The finding of larger difference in distal, as compared with proximal CRC mortality, between interested responders and nonresponders, would support the hypothesis of an association between reduced risk of death and higher education and/or awareness, as timeliness in seeking care for alarming symptoms is likely to have a larger impact in these cases (30, 31) . CRC risk awareness may thus represent a component of the SES mortality gradient. with squamous, and 20 with basal cell carcinomas, 12 with carcinoid tumors, two with metastatic cancers, two with melanoma, two with sarcoma, and one with lymphoma) were excluded from the incidence analysis. CI = confidence interval; IR = incidence rate. † Number of subjects used for the estimates in the multivariable model. ‡ Multivariable Cox regression model; HR is adjusted for all the variables included in the model.
Even if we have no information on the management of CRC patients, it seems unlikely that differential access to effective treatment might explain the observed differences across response groups. The findings from surveys of diagnostic and treatment modalities among CRC patients in the study areas (29, 32) suggested that timing and appropriateness of CRC management does not differ substantially by subject's SES once the diagnosis has been made.
Both interested and uninterested responders showed a lower overall mortality compared with nonresponders, which would suggest that responders represented a self-selected subgroup of healthoriented subjects within the general target population. However, as we did not collect information concerning health-related behaviors, or prevalence of comorbidities, we cannot assess the possible role of a differential distribution of these determinants.
The restriction of the analysis to the population targeted in two out of six trial centers represents a limitation of our study. However, these two centers provided 65% of the subjects who received the interest in screening questionnaire, 65% of those who responded, and 60% of those enrolled. Therefore, it seems unlikely that the characteristics of subjects who volunteered for the trial might be different in the other centers, showing a similar response rate.
Availability of nearly complete demographics, CRC risk and vital status information at the individual level for all subjects included in the analysis, together with a very low proportion of losses at follow-up, represent strengths of the present study. Also, data from local cancer registries ensure high-quality information on CRC incidence, while the results of the review of the death certificates of people recruited in the trial showed a very low misclassification rate (13) .
In conclusion, responders expressing their interest in having screening represented a better-educated, health-conscious subgroup of the target population of the SCORE trial, showing similar CRC incidence and a substantially reduced overall, as well as CRC, mortality. We can therefore assume that the implementation of a population-based screening program with FS would result in a similar reduction in CRC incidence, as observed in the trial. Efforts aimed at increasing CRC awareness in the general population could enhance screening participation also among nonresponders, resulting in a larger impact on CRC mortality.
